Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 18 Jan 2022 |
10 | Journal Copy | 19 Jun 2024 |
11 | Certificate | 06 Jul 2024 |
2 | Reply to Exam Report (MIS-R) | 08 Feb 2022 |
3 | Reply to Exam Report (MIS-R) | 11 Feb 2022 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 24 Aug 2022 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 16 Feb 2023 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 09 Aug 2023 |
7 | Documents in support of Show cause Hearing (SCH) | 21 Aug 2023 |
8 | Reply to Exam Report (MIS-R) | 22 Aug 2023 |
9 | Authorization Letter | 02 Feb 2024 |
1 | EXAMINATION REPORT | 12977402 | 08 Feb 2022 | |
2 | Hearing Notice (Show Cause) | 17047158 | 05 Jan 2024 | |
3 | Tribunal Accepted Notice for : 5289083 | 17309380 | 6522075 | 05 Feb 2024 |
The application for Olmechoice was made on 18 January 2022.
The trademark applicant for Olmechoice is Abbott Healthcare Private Limited.
Olmechoice is applied in class(es) 5.
Application for Olmechoice is on Registered stage.
Application Id allotted to Olmechoice is 5289083.
Trademark agent or attorney for the application is Zeusip Advocates Llp.
Olmechoice filed with the Intellectual property office as a WORD.